SEC Form 4 · accession 0001551986-18-000021
INNOVATE BIOPHARMACEUTICALS, INC. · INNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher P. Prior
Officer — Chief Executive Officer · Director
Period of report
Aug 28, 2018
Accepted (ET)
Aug 28, 2018 · 6:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551986
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Aug 28, 2018 | P | 1,000 | $4.93 | A | 1,000 | D |
Table II — derivative securities
No Table II lines on this filing.